{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:03:29Z","timestamp":1792238609093,"version":"4.4.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.semnephrol.2025.151571","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T04:29:09Z","timestamp":1741667349000},"page":"151571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["IgA Vasculitis and IgA Nephropathy: Two Sides of the Same Coin?"],"prefix":"10.1016","volume":"44","author":[{"given":"Evang\u00e9line","family":"Pillebout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0001","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-3476(85)80459-5","article-title":"Berger disease: Henoch-Sch\u00f6nlein syndrome without the rash","volume":"106","author":"Meadow","year":"1985","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0002","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000185813","article-title":"Henoch-Sch\u00f6nlein purpura and IgA nephropathy in father and son","volume":"54","author":"Montoliu","year":"1990","journal-title":"Nephron"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0003","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000188822","article-title":"IgA nephropathy and Henoch-Sch\u00f6nlein syndrome occurring in the same patient","volume":"72","author":"Ravelli","year":"1996","journal-title":"Nephron"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151571_bib0004","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/ckj\/sft029","article-title":"Henoch-Schonlein purpura in a renal transplant recipient with prior IgA nephropathy following influenza vaccination","volume":"6","author":"McNally","year":"2013","journal-title":"Clin Kidney J"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151571_bib0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0272-6386(88)80028-3","article-title":"Is Henoch-Schonlein purpura the systemic form of IgA nephropathy?","volume":"12","author":"Waldo","year":"1988","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151571_bib0006","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2215\/CJN.06710810","article-title":"Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy","volume":"6","author":"Davin","year":"2011","journal-title":"CJASN"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151571_bib0007","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MOP.0b013e3282f4308b","article-title":"IgA nephropathy and Henoch\u2013Sch\u00f6nlein purpura nephritis","volume":"20","author":"Sanders","year":"2008","journal-title":"Curr Opin Pediatr"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151571_bib0008","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.3390\/jcm10112310","article-title":"IgA vasculitis and IgA nephropathy: same disease?","volume":"10","author":"Pillebout","year":"2021","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151571_bib0009","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1007\/s00467-020-04818-7","article-title":"IgA vasculitis nephritis in children and adults: one or different entities?","volume":"36","author":"Peruzzi","year":"2021","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151571_bib0010","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00467-022-05798-6","article-title":"Diagnosis and treatment of IgA nephropathy and IgA vasculitis nephritis in Chinese children","volume":"38","author":"Zhong","year":"2023","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151571_bib0011","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/ndt\/gfx189","article-title":"Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey","volume":"33","author":"O'Shaughnessy","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"9341","key":"10.1016\/j.semnephrol.2025.151571_bib0012","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(02)11279-7","article-title":"Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins","volume":"360","author":"Gardner-Medwin","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151571_bib0013","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/rheumatology\/keh544","article-title":"A nationwide survey on epidemiological characteristics of childhood Henoch-Schonlein purpura in Taiwan","volume":"44","author":"Yang","year":"2005","journal-title":"Rheumatol Oxf"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151571_bib0014","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s10067-016-3402-y","article-title":"Nationwide epidemiological survey of childhood IgA vasculitis associated hospitalization in the USA","volume":"35","author":"Okubo","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151571_bib0015","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s004670100582","article-title":"Pathophysiology and treatment of IgA nephropathy in children","volume":"16","author":"Yoshikawa","year":"2001","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151571_bib0016","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s40620-020-00767-4","article-title":"Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children: a retrospective 1243 cases analysis from single centre experience","volume":"33","author":"Wu","year":"2020","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151571_bib0017","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/ki.2015.252","article-title":"New developments in the genetics, pathogenesis, and therapy of IgA nephropathy","volume":"88","author":"Magistroni","year":"2015","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151571_bib0018","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.berh.2004.11.006","article-title":"What is known about the epidemiology of the vasculitides?","volume":"19","author":"Watts","year":"2005","journal-title":"Best Pr Res Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151571_bib0019","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7748\/paed.22.10.30.s27","article-title":"An epidemiological study of Henoch-Schonlein purpura","volume":"22","author":"Penny","year":"2010","journal-title":"Paediatr Nurs"},{"issue":"2 Suppl 89","key":"10.1016\/j.semnephrol.2025.151571_bib0020","first-page":"S11","article-title":"Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies","volume":"33","author":"Romero-G\u00f3mez","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151571_bib0021","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/bjd.12946","article-title":"Incidence of IgA vasculitis in the adult Slovenian population","volume":"171","author":"Ho\u010devar","year":"2014","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0022","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003822","article-title":"Epidemiology and clinical characteristics of biopsy-confirmed adult-onset IgA vasculitis in southern Sweden","volume":"10","author":"Thalen","year":"2024","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151571_bib0023","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/03009742.2017.1412497","article-title":"Epidemiology of primary systemic vasculitis in children: a population-based study from southern Sweden","volume":"47","author":"Mossberg","year":"2018","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151571_bib0024","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.ASN.0000013883.99976.22","article-title":"Henoch-Schonlein purpura in adults: outcome and prognostic factors","volume":"13","author":"Pillebout","year":"2002","journal-title":"JASN"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0025","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1038\/s41598-018-23638-2","article-title":"Renal prognosis and related risk factors for Henoch-Sch\u00f6nlein purpura nephritis: a Chinese adult patient cohort","volume":"8","author":"Huang","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151571_bib0026","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ndt\/gfq665","article-title":"The incidence of primary glomerulonephritis worldwide: a systematic review of the literature","volume":"26","author":"McGrogan","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151571_bib0027","first-page":"2340","article-title":"The incidence and prevalence of IgA nephropathy in Europe","volume":"38","author":"Willey","year":"2023","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151571_bib0028","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000495751","article-title":"Pediatric IgA nephropathy in Europe","volume":"5","author":"Coppo","year":"2019","journal-title":"Kidney Dis"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151571_bib0029","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","article-title":"Long-term outcomes in IgA nephropathy","volume":"18","author":"Pitcher","year":"2023","journal-title":"CJASN"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151571_bib0030","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s10157-015-1177-0","article-title":"Clinical manifestations of Henoch-Schonlein purpura nephritis and IgA nephropathy: comparative analysis of data from the Japan Renal Biopsy Registry (J-RBR)","volume":"20","author":"Komatsu","year":"2016","journal-title":"Clin Exp Nephrol"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151571_bib0031","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s40620-023-01687-9","article-title":"Renal pathology in adult and paediatric population of Japan: review of the Japan renal biopsy registry database from 2007 to 2017","volume":"36","author":"Goto","year":"2023","journal-title":"J Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0032","first-page":"8","article-title":"New insights into the pathogenesis of IgA nephropathy","volume":"1","author":"Novak","year":"2015","journal-title":"Kidney Basel"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151571_bib0033","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00467-021-04950-y","article-title":"IgA vasculitis with nephritis: update of pathogenesis with clinical implications","volume":"37","author":"Hastings","year":"2022","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151571_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188718","article-title":"Biomarkers of IgA vasculitis nephritis in children","volume":"12","author":"Pillebout","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151571_bib0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5114\/ceji.2021.108177","article-title":"Relationship between Gd-IgA1 and TNFR1 in IgA nephropathy and IgA vasculitis nephritis in children: multicenter study","volume":"46","author":"Mizerska-Wasiak","year":"2021","journal-title":"Cent-Eur J Immunol"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151571_bib0036","first-page":"2117","article-title":"Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis","volume":"35","author":"Zhang","year":"2020","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151571_bib0037","doi-asserted-by":"crossref","first-page":"683","DOI":"10.5301\/jn.5000218","article-title":"Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features","volume":"26","author":"Xin","year":"2013","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151571_bib0038","article-title":"The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies","volume":"3","author":"Cheung","year":"2023","journal-title":"Front Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151571_bib0039","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1620\/tjem.240.199","article-title":"Different expression patterns of toll-like receptor mRNAs in blood mononuclear cells of IgA nephropathy and IgA vasculitis with nephritis","volume":"240","author":"Saito","year":"2016","journal-title":"Tohoku J Exp Med"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151571_bib0040","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3892\/etm.2023.11999","article-title":"Proanthocyanidins: a novel approach to Henoch-Schonlein purpura through balancing immunity and arresting oxidative stress via TLR4\/MyD88\/NF-\u03baB signaling pathway (review)","volume":"25","author":"Xie","year":"2023","journal-title":"Exp Ther Med"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151571_bib0041","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/nep.13477","article-title":"High levels of urinary complement proteins are associated with chronic renal damage and proximal tubule dysfunction in immunoglobulin A nephropathy","volume":"24","author":"Wen","year":"2019","journal-title":"Nephrol Carlton Vic"},{"key":"10.1016\/j.semnephrol.2025.151571_bib0042","article-title":"Complement activation is associated with crescents in IgA nephropathy","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151571_bib0043","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00467-022-05585-3","article-title":"Clinical relevance of glomerular C4d deposition in children with early IgA nephropathy or Henoch-Sch\u00f6nlein purpura nephropathy","volume":"38","author":"Wu","year":"2023","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151571_bib0044","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1093\/ckj\/sfad236","article-title":"Urinary markers of the alternative and lectin complement pathway are increased in IgA vasculitis nephritis","volume":"16","author":"Marro","year":"2023","journal-title":"Clin Kidney J"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151571_bib0045","article-title":"The interaction between circulating complement proteins and cutaneous microvascular endothelial cells in the development of childhood Henoch-Sch\u00f6nlein purpura","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151571_bib0046","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1681\/ASN.2014101000","article-title":"Current understanding of the role of complement in IgA nephropathy","volume":"26","author":"Maillard","year":"2015","journal-title":"JASN"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151571_bib0047","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.kint.2017.03.043","article-title":"Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy","volume":"92","author":"Medjeral-Thomas","year":"2017","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151571_bib0048","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/ped.13461","article-title":"Serum IgA\/C3 and glomerular C3 staining predict severity of IgA nephropathy","volume":"60","author":"Kawasaki","year":"2018","journal-title":"Pediatr Int"},{"key":"10.1016\/j.semnephrol.2025.151571_bib0049","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3389\/fimmu.2019.00504","article-title":"The emerging role of complement proteins as a target for therapy of IgA nephropathy","volume":"10","author":"Rizk","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.semnephrol.2025.151571_bib0050","doi-asserted-by":"crossref","first-page":"e16-e16","DOI":"10.34172\/jnp.2021.16","article-title":"Relevance of glomerular C4d deposition in pediatric patients with Henoch-Sch\u00f6nlein purpura compared to IgA nephritis","volume":"10","author":"Benz","year":"2020","journal-title":"J Nephropathol"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151571_bib0051","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.autrev.2017.10.009","article-title":"New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Sch\u00f6nlein purpura)","volume":"16","author":"Heineke","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0052","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ki.2011.16","article-title":"Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schonlein purpura nephritis","volume":"80","author":"Kiryluk","year":"2011","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151571_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002765","article-title":"Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis","volume":"8","author":"Kiryluk","year":"2012","journal-title":"PLoS Genet"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151571_bib0054","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/s41588-023-01422-x","article-title":"Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy","volume":"55","author":"Kiryluk","year":"2023","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151571_bib0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.autrev.2017.11.024","article-title":"Genetics of immunoglobulin-A vasculitis (Henoch-Sch\u00f6nlein purpura): an updated review","volume":"17","author":"L\u00f3pez-Mej\u00edas","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151571_bib0056","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24457","article-title":"Genome-wide association study of 7661 Chinese Han individuals and fine-mapping major histocompatibility complex identifies HLA-DRB1 as associated with IgA vasculitis","volume":"36","author":"Xia","year":"2022","journal-title":"J Clin Lab Anal."},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151571_bib0057","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/rheumatology\/keab443","article-title":"Identification of a shared genetic risk locus for Kawasaki disease and immunoglobulin A vasculitis by a cross-phenotype meta-analysis","volume":"61","author":"Carmona","year":"2022","journal-title":"Rheumatol Oxf Engl"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151571_bib0058","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3390\/ijms25020882","article-title":"HLA polymorphisms and clinical manifestations in IgA vasculitis","volume":"25","author":"Held","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151571_bib0059","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s00467-024-06361-1","article-title":"Are children with IgA nephropathy different from adult patients?","volume":"39","author":"Su","year":"2024","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151571_bib0060","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/ard.2009.116657","article-title":"EULAR\/PRINTO\/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria","volume":"69","author":"Ozen","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151571_bib0061","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/rheumatology\/kez041","article-title":"European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis: the SHARE initiative","volume":"58","author":"Ozen","year":"2019","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151571_bib0062","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1093\/rheumatology\/keaa921","article-title":"Impact of aging on phenotype and prognosis in IgA vasculitis","volume":"60","author":"Audemard-Verger","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.semnephrol.2025.151571_bib0063","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.853724","article-title":"New insights and challenges associated with IgA vasculitis and IgA vasculitis with nephritis: is it time to change the paradigm of the most common systemic vasculitis in childhood?","volume":"10","author":"Jelusic","year":"2022","journal-title":"Front Pediatr"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151571_bib0064","first-page":"808","article-title":"[A clinico-pathological study comparing Henoch-Schonlein purpura nephritis with IgA nephropathy in children]","volume":"41","author":"Zhou","year":"2003","journal-title":"Chin J Pediatr"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151571_bib0065","first-page":"2334","article-title":"Clinico-pathological association of Henoch-Schoenlein purpura nephritis and IgA nephropathy in children","volume":"8","author":"Mao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0066","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s12887-023-04243-3","article-title":"Comparative study on clinicopathological features and prognosis of IgA vasculitis nephritis and IgA nephropathy in children","volume":"23","author":"Lv","year":"2023","journal-title":"BMC Pediatr"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0067","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12882-024-03465-6","article-title":"Characteristics of renal pathology and coagulation function in IgA nephropathy and IgA vasculitis associated nephritis","volume":"25","author":"Wang","year":"2024","journal-title":"BMC Nephrol"},{"issue":"1 Suppl 75","key":"10.1016\/j.semnephrol.2025.151571_bib0068","first-page":"S45","article-title":"Henoch-Schonlein purpura nephritis and IgA nephropathy: a comparative clinical study","volume":"31","author":"Calvo-Rio","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151571_bib0069","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ki.2012.302","article-title":"Clinical outcomes, when matched at presentation, do not vary between adult-onset Henoch-Schonlein purpura nephritis and IgA nephropathy","volume":"82","author":"Oh","year":"2012","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151571_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232194","article-title":"A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Sch\u00f6nlein purpura nephritis and IgA nephropathy","volume":"15","author":"Sugiyama","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0071","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1471-2369-14-169","article-title":"Validation of the absolute renal risk of dialysis\/death in adults with IgA nephropathy secondary to Henoch-Sch\u00f6nlein purpura: a monocentric cohort study","volume":"14","author":"Mohey","year":"2013","journal-title":"BMC Nephrol"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151571_bib0072","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s11255-021-03063-7","article-title":"Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy","volume":"54","author":"Torun Bayram","year":"2022","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151571_bib0073","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ekir.2018.07.021","article-title":"Clinical characteristics and treatment patterns of children and adults with IgA nephropathy or IgA vasculitis: findings from the CureGN study","volume":"3","author":"Selewski","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151571_bib0074","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1523-1755.2001.059003823.x","article-title":"What is the difference between IgA nephropathy and Henoch-Schonlein purpura nephritis?","volume":"59","author":"Davin","year":"2001","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151571_bib0075","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151571_bib0076","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/modpathol.2013.222","article-title":"Using the Oxford classification of IgA nephropathy to predict long-term outcomes of Henoch-Schonlein purpura nephritis in adults","volume":"27","author":"Kim","year":"2014","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0077","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12882-018-1009-z","article-title":"Clinical impact of endocapillary proliferation according to the Oxford classification among adults with Henoch-Sch\u00f6nlein purpura nephritis: a multicenter retrospective cohort study","volume":"19","author":"Inagaki","year":"2018","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151571_bib0078","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40620-017-0457-z","article-title":"Value of the Oxford classification of IgA nephropathy in children with Henoch\u2013Sch\u00f6nlein purpura nephritis","volume":"31","author":"Xu","year":"2018","journal-title":"J Nephrol"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151571_bib0079","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s10157-019-01777-8","article-title":"A clinicopathological comparison between IgA nephropathy and Henoch\u2013Sch\u00f6nlein purpura nephritis in children: use of the Oxford classification","volume":"23","author":"Li","year":"2019","journal-title":"Clin Exp Nephrol"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151571_bib0080","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10157-019-01726-5","article-title":"A retrospective analysis of children with Henoch-Schonlein purpura and re-evaluation of renal pathologies using Oxford classification","volume":"23","author":"\u00c7ak\u0131c\u0131","year":"2019","journal-title":"Clin Exp Nephrol"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151571_bib0081","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s00467-019-04327-2","article-title":"Does MEST-C score predict outcomes in pediatric Henoch-Sch\u00f6nlein purpura nephritis?","volume":"34","author":"Jimenez","year":"2019","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151571_bib0082","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2215\/CJN.0000000000000398","article-title":"Histologic and clinical factors associated with kidney outcomes in IgA vasculitis nephritis","volume":"19","author":"Barbour","year":"2024","journal-title":"CJASN"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151571_bib0083","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.3906\/sag-2104-319","article-title":"Clinicopathologic comparisons of IgA nephropathy and IgA vasculitis nephropathy in children: a ten-year single-center experience","volume":"51","author":"Su","year":"2021","journal-title":"Turk J Med Sci"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0084","first-page":"182","article-title":"Clinical and histological comparison of IgA nephritis and renal IgA vasculitis","volume":"40","author":"Friedrich","year":"2024","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151571_bib0085","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/sj.ki.5002185","article-title":"Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels","volume":"71","author":"Moldoveanu","year":"2007","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151571_bib0086","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/ndt\/gfv221","article-title":"Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy","volume":"30","author":"Yasutake","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0087","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10157-018-1582-2","article-title":"Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis","volume":"23","author":"Suzuki","year":"2019","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151571_bib0088","first-page":"1579","article-title":"Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort","volume":"33","author":"Berthelot","year":"2018","journal-title":"Nephrol Dial Transpl"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151571_bib0089","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s00467-021-05107-7","article-title":"A systematic review of urine biomarkers in children with IgA vasculitis nephritis","volume":"36","author":"Williams","year":"2021","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151571_bib0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.krcp.2014.07.004","article-title":"Clinicopathological role of kidney injury molecule-1 in immunoglobulin A nephropathy","volume":"33","author":"Lee","year":"2014","journal-title":"Kidney Res Clin Pract"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151571_bib0091","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1159\/000494442","article-title":"Urinary biomarkers in the prediction of prognosis and treatment response in IgA nephropathy","volume":"43","author":"Neuhaus","year":"2018","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0092","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12882-024-03574-2","article-title":"Clinical significance of urinary inflammatory biomarkers in patients with IgA nephropathy","volume":"25","author":"Yoon","year":"2024","journal-title":"BMC Nephrol"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151571_bib0093","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/ki.2012.280","article-title":"The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines\u2014application to the individual patient","volume":"82","author":"Radhakrishnan","year":"2012","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151571_bib0094","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.kint.2018.10.018","article-title":"Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"95","author":"Floege","year":"2019","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151571_bib0095","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ki.2010.150","article-title":"Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schonlein purpura","volume":"78","author":"Pillebout","year":"2010","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151571_bib0096","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/art.40178","article-title":"Characteristics and management of IgA vasculitis (Henoch-Schonlein) in adults: data from 260 patients included in a French multicenter retrospective survey","volume":"69","author":"Audemard-Verger","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151571_bib0097","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1681\/ASN.2016060640","article-title":"A randomized, controlled trial of Rituximab in IgA nephropathy with proteinuria and renal dysfunction","volume":"28","author":"Lafayette","year":"2017","journal-title":"JASN"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0098","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.40339","article-title":"Brief report: Rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schonlein)","volume":"70","author":"Maritati","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semnephrol.2025.151571_bib0099","article-title":"Interventions for preventing and treating kidney disease in Henoch-Schonlein purpura (HSP) (review)","volume":"8","author":"Hahn","year":"2015","journal-title":"Cochrane Libr"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151571_bib0100","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/archdischild-2013-303642","article-title":"Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein purpura (HSP)","volume":"98","author":"Dudley","year":"2013","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151571_bib0101","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jpeds.2006.03.024","article-title":"Early prednisone therapy in Henoch-Schonlein purpura: a randomized, double-blind, placebo-controlled trial","volume":"149","author":"Ronkainen","year":"2006","journal-title":"J Pediatr"},{"issue":"4S","key":"10.1016\/j.semnephrol.2025.151571_bib0102","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2025.151571_bib0103","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejim.2023.04.022","article-title":"Comparative effectiveness and safety for the treatments despite optimized renin-angiotensin system blockade among IgA nephropathy patients at high-risk of disease progression: a network meta-analysis of randomized controlled trials","volume":"114","author":"Tan","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0104","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.kint.2021.03.033","article-title":"A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy","volume":"100","author":"Wheeler","year":"2021","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/ckj\/sfac214","article-title":"Zonulin, as a marker of intestinal permeability, is elevated in IgA nephropathy and IgA vasculitis with nephritis","volume":"16","author":"Li","year":"2023","journal-title":"Clin Kidney J"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151571_bib0106","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00467-007-0623-y","article-title":"Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schonlein purpura","volume":"22","author":"Lau","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0107","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10157-020-01968-8","article-title":"Serum levels of galactose-deficient IgA1 in Chinese children with IgA nephropathy, IgA vasculitis with nephritis, and IgA vasculitis","volume":"25","author":"Tang","year":"2021","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151571_bib0108","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/ijms21041389","article-title":"Immunological pattern in IgA nephropathy","volume":"21","author":"Esteve Cols","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151571_bib0109","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.ekir.2019.08.015","article-title":"Autoantibodies specific for galactose-deficient IgA1 in IgA vasculitis with nephritis","volume":"4","author":"Suzuki","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.semnephrol.2025.151571_bib0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbacli.2016.02.002","article-title":"Urinary myeloid IgA Fc alpha receptor (CD89) and transglutaminase-2 as new biomarkers for active IgA nephropathy and Henoch-Schonlein purpura nephritis","volume":"5","author":"Moresco","year":"2016","journal-title":"BBA Clin"},{"issue":"7\u20138","key":"10.1016\/j.semnephrol.2025.151571_bib0111","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.clinbiochem.2013.01.017","article-title":"Soluble transferrin receptor in urine, a new biomarker for IgA nephropathy and Henoch-Schonlein purpura nephritis","volume":"46","author":"Delanghe","year":"2013","journal-title":"Clin Biochem"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151571_bib0112","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1681\/ASN.2007121311","article-title":"Toll-like receptor 9 affects severity of IgA nephropathy","volume":"19","author":"Suzuki","year":"2008","journal-title":"JASN"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151571_bib0113","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/ndt\/gfr403","article-title":"Tonsillar TLR9 expression and efficacy of tonsillectomy with steroid pulse therapy in IgA nephropathy patients","volume":"27","author":"Sato","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151571_bib0114","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00467-014-2807-6","article-title":"Toll-like receptors, immunoproteasome and regulatory T cells in children with Henoch-Schonlein purpura and primary IgA nephropathy","volume":"29","author":"Donadio","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151571_bib0115","first-page":"622","article-title":"Urinary protein array analysis to identify key inflammatory markers in children with IgA vasculitis nephritis","volume":"9","author":"Marro","year":"2022","journal-title":"Child Basel Switz"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151571_bib0116","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/nep.13580","article-title":"Variation in complement factor H affects complement activation in immunoglobulin A vasculitis with nephritis","volume":"25","author":"Jia","year":"2020","journal-title":"Nephrology"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929525000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929525000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T14:49:57Z","timestamp":1746542997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929525000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":116,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0270929525000087"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2025.151571","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgA Vasculitis and IgA Nephropathy: Two Sides of the Same Coin?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2025.151571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151571"}}